PubRank

S Iwatsuki

Author PubWeight™ 363.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evolution of liver transplantation. Hepatology 1982 19.54
2 A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet 1984 10.33
3 The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980 7.40
4 Venous bypass in clinical liver transplantation. Ann Surg 1984 7.04
5 Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med 1981 6.95
6 Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 5.77
7 Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984 5.74
8 Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985 5.70
9 Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet 1984 5.16
10 Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 1984 4.49
11 A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet 1985 4.29
12 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994 4.16
13 Role of liver transplantation in cancer therapy. Ann Surg 1985 4.08
14 Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985 3.91
15 Hepatic Retransplantation. Transplant Proc 1985 3.62
16 Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet 1982 3.49
17 Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1981 3.38
18 Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron 1987 3.26
19 Liver transplantation before 1 year of age. J Pediatr 1987 3.15
20 Fungal infections in liver transplant recipients. Transplantation 1985 3.07
21 Experience with 150 liver resections. Ann Surg 1983 3.01
22 Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987 2.95
23 Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet 1981 2.92
24 Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984 2.91
25 Liver transplantation in adults. Hepatology 1982 2.89
26 Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet 1985 2.88
27 Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986 2.84
28 Successful liver transplantation from crossmatch-positive donors. Transplant Proc 1981 2.80
29 Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg 1978 2.80
30 Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985 2.59
31 The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997 2.57
32 Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc 1981 2.49
33 Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet 1982 2.42
34 Liver transplantation across ABO blood groups. Surgery 1986 2.39
35 The antibody crossmatch in liver transplantation. Surgery 1986 2.33
36 The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994 2.32
37 Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol 1988 2.21
38 Left hepatic trisegmentectomy. Surg Gynecol Obstet 1982 2.16
39 Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985 2.16
40 A growth factor in fine vascular anastomoses. Surg Gynecol Obstet 1984 2.15
41 Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987 2.11
42 Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986 2.07
43 Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics 1986 2.04
44 Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc 1985 1.98
45 Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 1984 1.96
46 Liver resection for metastatic colorectal cancer. Surgery 1986 1.92
47 Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988 1.89
48 Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics 1984 1.86
49 Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med 1973 1.85
50 Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 1982 1.84
51 Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000 1.82
52 Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. J Am Coll Surg 1994 1.81
53 Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg 1979 1.80
54 Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc 1991 1.77
55 Current status of hepatic transplantation. Semin Liver Dis 1983 1.75
56 Factors in the Development of Liver Transplantation. Transplant Proc 1985 1.74
57 Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc 1973 1.73
58 Retransplantation of the liver. Semin Liver Dis 1985 1.73
59 Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998 1.72
60 Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980 1.69
61 Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991 1.68
62 Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 1986 1.63
63 Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis 1985 1.62
64 Liver transplantation: an unfinished product. Transplant Proc 1989 1.61
65 Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J Surg Res 1978 1.60
66 Liver transplantation for fulminant hepatic failure. Semin Liver Dis 1985 1.56
67 Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients. Transplant Proc 1985 1.55
68 Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr 1982 1.54
69 Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999 1.54
70 Cholangiography and interventional biliary radiology in adult liver transplantation. AJR Am J Roentgenol 1985 1.54
71 Angiography of liver transplantation patients. Radiology 1985 1.53
72 Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987 1.53
73 Medical aspects of liver transplantation. Hepatology 1984 1.52
74 Cyclosporine monitoring in liver transplant patients. Transplantation 1985 1.51
75 Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988 1.50
76 Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986 1.46
77 Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988 1.45
78 Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992 1.45
79 Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981 1.38
80 Excisional treatment of cavernous hemangioma of the liver. Ann Surg 1980 1.37
81 Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997 1.36
82 Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997 1.36
83 Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease. Transplant Proc 1983 1.36
84 The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992 1.35
85 OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc 1987 1.35
86 Linear growth following pediatric liver transplantation. Am J Dis Child 1987 1.33
87 Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr 1985 1.32
88 Primary cancers of extrahepatic biliary passages. Int J Radiat Oncol Biol Phys 1985 1.29
89 Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet 1983 1.29
90 Pediatric Liver Transplantation Under Therapy With Cyclosporin-A and Steroids. Transplant Proc 1983 1.28
91 Successful small bowel allotransplantation in dogs with cyclosporine and prednisone. Transplantation 1984 1.28
92 Analysis of liver transplantation. Hepatology 1984 1.26
93 Liver transplantation for hepatocellular carcinoma. World J Surg 1995 1.26
94 Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet 1990 1.25
95 Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990 1.24
96 Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987 1.23
97 Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988 1.22
98 Budd-Chiari syndrome with obstruction of the inferior vena cava. Gastroenterology 1968 1.22
99 Liver transplantation in older patients. N Engl J Med 1987 1.20
100 Liver transplantation for type I glycogen storage disease. Lancet 1983 1.20
101 Childbearing after liver transplantation. Transplantation 1990 1.19
102 Measurement of portal pressure and its clinical application. Am J Med 1970 1.19
103 Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 1995 1.17
104 Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989 1.17
105 Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995 1.15
106 Liver transplantation in the ciclosporin era. Prog Allergy 1986 1.14
107 Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr 1987 1.14
108 Hepatic resection for cystic lesions of the liver. Ann Surg 1993 1.14
109 Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol 1984 1.13
110 Liver transplantation in patients with patent splenorenal shunts. Surgery 1987 1.12
111 Indications for pediatric liver transplantation. J Pediatr 1987 1.12
112 Transplantation for primary biliary cirrhosis. Gastroenterology 1988 1.12
113 Liver transplantation for malignant tumors. Gastroenterol Clin North Am 1988 1.09
114 Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992 1.09
115 Liver transplantation for biliary atresia. World J Surg 1984 1.09
116 Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol 1990 1.09
117 The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc 1991 1.08
118 Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol 1987 1.07
119 Liver transplantation under cyclosporine: a decade of experience. Transplant Proc 1991 1.07
120 Adenoviral infections in pediatric liver transplant recipients. JAMA 1987 1.06
121 Epithelioid hemangioendothelioma of liver. Clinicopathological correlation of 10 cases treated by orthotopic liver transplantation. Am J Surg Pathol 1989 1.04
122 Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc 1973 1.04
123 Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 1985 1.04
124 Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplant Proc 1993 1.03
125 Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997 1.03
126 Liver resection combined with excision of vena cava. J Am Coll Surg 2000 1.02
127 Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2. Cancer 1989 1.02
128 Advantages of venous bypass during orthotopic transplantation of the liver. Semin Liver Dis 1985 1.02
129 Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet 1981 1.01
130 Pseudolymphoma in renal allograft recipients. Arch Surg 1978 1.00
131 Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989 0.99
132 Late mortality and morbidity after liver transplantation. Transplant Proc 1987 0.95
133 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology 1982 0.95
134 Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc 1987 0.95
135 Development and organization of a multiple organ transplantation program. Ann Surg 1986 0.95
136 The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991. J Surg Oncol Suppl 1993 0.95
137 Steps in immunosuppression for renal transplantation. Kidney Int Suppl 1983 0.93
138 Effect of increased intraabdominal pressure on hepatic hemodynamics in patients with chronic liver disease and portal hypertension. Gastroenterology 1973 0.93
139 Liver replacement after massive hepatic trauma. J Trauma 1987 0.92
140 Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet 1989 0.92
141 Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989 0.92
142 Percutaneous transhepatic cholangiography rather than ultrasound as a screening test for postoperative biliary complications in liver transplant patients. Transplant Proc 1988 0.92
143 Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts. Transplant Proc 1988 0.91
144 Total pancreaticoduodenal homotransplantation in dogs immunosuppressed with cyclosporine and steroids. Am J Surg 1984 0.90
145 Hepatic complications. Surg Clin North Am 1977 0.90
146 Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology 2001 0.90
147 Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity. Transplantation 1983 0.89
148 Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis 1985 0.89
149 Effect of danazol on cyclosporine pharmacokinetics. Transplantation 1988 0.89
150 Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer 1991 0.89
151 Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993 0.89
152 Cyclosporine trough concentration monitoring in liver transplant patients. Transplant Proc 1986 0.88
153 Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. Transplant Proc 1983 0.88
154 The late results of terminal esophagoproximal gastrectomy (TEPG) with intensive devascularization and splenectomy for bleeding esophageal varices in cirrhosis. Surgery 1976 0.88
155 Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987 0.87
156 Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 1991 0.87
157 Liver transplantation for fulminant hepatic failure. ASAIO J 1994 0.87
158 Mixed lymphocyte culture and graft rejection. Surg Forum 1973 0.87
159 Effect of OKT3 on survival and rate of retransplantation. Transplant Proc 1987 0.87
160 Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer 1990 0.87
161 Survival of a homologous parathyroid implant in an immunosuppressed patient. Lancet 1973 0.86
162 Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc 1987 0.86
163 Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 1991 0.86
164 Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2. Cancer Immunol Immunother 1988 0.85
165 Percutaneous transhepatic balloon dilatation of benign biliary strictures. AJR Am J Roentgenol 1987 0.85
166 Surgical complications in human orthotopic liver transplantation. Acta Chir Belg 1987 0.85
167 Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer Immunol Immunother 1991 0.85
168 Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron 1987 0.85
169 Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992 0.85
170 Spindle cell tumor of the portal vein. J Surg Oncol 1995 0.84
171 Estradiol and testosterone levels in patients undergoing partial hepatectomy. A possible signal for hepatic regeneration? Dig Dis Sci 1989 0.84
172 Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma. Hepatogastroenterology 1991 0.84
173 Progress in liver transplantation. Adv Surg 1988 0.83
174 Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc 1987 0.83
175 Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? Transpl Int 1988 0.83
176 Recovery from hepatorenal syndrome after successful orthotopic liver transplantation. Surg Forum 1973 0.82
177 Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography. Transplant Proc 1986 0.82
178 Liver transplantation in the treatment of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 1998 0.81
179 Enhanced expression of hepatocyte growth factor and c-Met mRNAs in isografts in experimental rat liver transplants. Transplant Proc 1993 0.81
180 Orthotopic liver transplantation for fulminant and subacute hepatic failure. Gastroenterol Clin North Am 1988 0.81
181 Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery 1988 0.81
182 Normotest and abnormal prothrombin in liver transplantation. Liver 1995 0.81
183 Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 1999 0.80
184 Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis 1988 0.80
185 Second cadaver kidney transplants: improved graft survival in secondary kidney transplants using cyclosporin A. J Urol 1984 0.80
186 Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int 1992 0.80
187 Current management of portal hypertension with liver transplantation. Adv Surg 1992 0.79
188 Clinical comparison of the end-to-side and side-to-side portacaval shunt: ten year follow-up. Ann Surg 1973 0.79
189 Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. Transplant Proc 1981 0.79
190 Past and future prospects of orthoptic liver transplantation. Arch Surg 1981 0.79
191 Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989 0.79
192 Amelioration of normothermic canine liver ischemia with prostacyclin. Transplant Proc 1988 0.79
193 Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG? Transplant Proc 1979 0.79
194 Liver Resection for Primary Hepatic Neoplasms. Acta Chir Austriaca 1988 0.79
195 The Denver-Pittsburgh liver transplant series. Clin Transpl 1987 0.79
196 Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc 1980 0.79
197 Infections in pediatric liver recipients treated for acute rejection. Transplant Proc 1989 0.78
198 Lymphapheresis in organ transplantation: preliminary report. Prog Clin Biol Res 1982 0.78
199 Regional cancer chemotherapy for advanced stage hepatocellular carcinoma. J Surg Oncol Suppl 1993 0.78
200 Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet 1983 0.78
201 Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids. Transplant Proc 1983 0.78
202 Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 1998 0.78
203 Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband. Hepatology 1983 0.78
204 Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants. Am J Kidney Dis 1985 0.78
205 The hepatic artery in orthotopic liver transplantation. Helv Chir Acta 1988 0.77
206 Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma. Hepatology 1997 0.77
207 Clinical considerations in orthotopic liver transplantation. Radiol Clin North Am 1987 0.76
208 The influence of liver dysfunction on cyclosporine pharmacokinetics--a comparison between 70 per cent hepatectomy and complete bile duct ligation in dogs. Jpn J Surg 1989 0.76
209 Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation 1973 0.76
210 Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. Arch Surg 1990 0.76
211 Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl 1994 0.76
212 Hilar cholangiocarcinoma associated with clonorchiasis. Dig Dis Sci 1989 0.75
213 Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine. Transplant Proc 1983 0.75
214 Orthotopic liver transplantation for fulminant and subacute hepatic failure. ASAIO Trans 1989 0.75
215 An Analysis of the Causes of Death After Pediatric Liver Transplantation. Transplant Proc 1988 0.75
216 Results with cyclosporine in renal transplantation in patients who have lost two previous allografts. Surg Gynecol Obstet 1987 0.75
217 WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation. Hosp Rec Study 1988 0.75
218 Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 1991 0.75
219 [Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center]. Helv Chir Acta 1989 0.75
220 The use of pulmonary artery sequestration as an hepatic arterial conduit. A case of unusual hepatic arterial supply. Transplantation 1989 0.75
221 Hepatectomy in children. Int Adv Surg Oncol 1982 0.75
222 Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion. Jpn J Surg 1974 0.75
223 Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. Transplant Proc 1992 0.75
224 Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplant Proc 1982 0.75
225 HLA antigens in primary sclerosing cholangitis. Transplant Proc 1992 0.75
226 Liver resectability based on physical characteristics. Cancer Treat Res 1994 0.75
227 Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors. Hepatology 1989 0.75
228 The reverse fistula for vascular access. Surg Gynecol Obstet 1977 0.75
229 Acute and chronic renal failure. Surg Clin North Am 1977 0.75
230 Immunological factors influencing liver graft survival. Gastroenterol Clin North Am 1988 0.75
231 [UNOS-selection criteria and order of priority for the candidate of liver transplantation]. Nihon Shokakibyo Gakkai Zasshi 2001 0.75
232 Nonanastomotic biliary strictures following right hepatic artery occlusion in transplant recipients. Transplant Proc 1994 0.75
233 Changes of portal venous flow velocity after liver transplantation and its causes. Transplant Proc 1994 0.75
234 Thermosensitive gels incorporating polythioether units for the selective extraction of class b metal ions. J Chromatogr A 2010 0.75
235 Posttransplant serum analysis in human kidney allografts. Transplant Proc 1981 0.75
236 A cause of hepatic encephalopathy after portacaval shunt. Jpn J Surg 1974 0.75
237 The true one-handed tie. Surg Gynecol Obstet 1982 0.75
238 Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma? JAMA 1997 0.75
239 Effect of FK 506 on experimental liver carcinogenesis. Transplant Proc 1991 0.75
240 Liver transplantation today. Postgrad Med 1987 0.75
241 [Our reconstructive method after pancreaticoduodenectomy]. Shujutsu 1969 0.75
242 Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors. Cancer Immunol Immunother 1989 0.75